Matthew Robson

Matthew Robson is a prominent figure in the pharmaceutical industry, currently serving as the Chief Medical Officer at Novartis Pharma K.K. in Japan. He has a robust background in medical affairs and has held various leadership roles across multiple organizations.

Educational Background

• Doctor of Philosophy (Ph.D.) in Magnetic Resonance Imaging Analysis from the University of Cambridge.
• Master of Arts (M.A.) in Physics and Theoretical Physics from the University of Cambridge.
• Completed post-doctoral research at Yale University School of Medicine, focusing on ultra-fast imaging methods.

Professional Experience

• Chief Medical Officer at Novartis Pharma K.K. where he oversees medical affairs and pharmacovigilance operations in Japan and the Asia-Pacific region.24
• Previously served as Vice President and Head of Medical Affairs for Greater Asia at BD and held senior roles at Janssen Pharma and other leading pharmaceutical companies.25
• Co-founded Perspectum Diagnostics, where he was instrumental in developing liver imaging technology, serving as the Chief Technical Officer since November 2017.13

Contributions and Impact

Dr. Robson is recognized for his innovative approach to integrating scientific advances into practical healthcare solutions, emphasizing data-driven transformations in medical affairs. His work aims to enhance patient outcomes through improved healthcare delivery models and collaborative approaches within the pharmaceutical industry.56

Overall, Matthew Robson's extensive experience in both academia and industry positions him as a key leader in advancing medical science and improving patient care within the pharmaceutical landscape.